gala semaglutide Direct Meds GLP-1 2026: Claims Examined, Pricing Verified & What Consumers Should Confirm Before Buying Eden vs GALA vs PlexusDx

Quick Verification Snapshot - Omzo GLP-1 (As of June 2026) Platform verified at: omzo.com (June 2026) Lander verified at: omzo.com/YT0S0AczACJxzyvB/weight-loss/v2 (June 2026) Terms verified at: omzo.com/terms-and-conditions (June 2026) Shipping Policy verified at: omzo.com/shipping-policy (June 2026) HIPAA Policy verified at: omzo.com/hipaa-policy (June 2026) Third-party trust credential: A trust credential seal appears on Omzo's published lander

If you have a personal or family history of inflammatory bowel disease, coeliac disease, or colorectal cancer, inform your prescriber, as this may influence monitoring strategies

The research, published Saturday in the New England Journal of Medicine, is significant because semaglutide was initially prescribed for adults with Type 2 diabetes, a condition in which cells don't respond normally to insulin, the hormone made by the pancreas

Adequate protein (1.21.6 g/kg body weight) is critical to preserving muscle mass during GLP-1 therapy, especially as appetite suppression reduces overall food intake